SEC Form 4 · accession 0000899243-19-000963
Zymeworks Inc. · ZYME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Kai Yuen Poon
Officer — See Remarks
Period of report
Jan 8, 2019
Accepted (ET)
Jan 10, 2019 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001403752
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.53 | Jan 8, 2019 | A | 25,000 | A | — | Jan 7, 2029 | Common Shares | 25,000 | 25,000 | D |
Explanation of responses
- F1Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.
Remarks
Vice President, Business Development